Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Alexion's C5 complement inhibitor effective in murine lupus model

Aug. 23, 1996

Cyclooxygenase-2 inhibitors from Merck Frosst

Aug. 23, 1996

Hyanalgese-D demonstrates negative efficacy in U.S. phase III trial

Aug. 23, 1996

KF-20444: Kyowa Hakko's novel antirheumatic agent

Aug. 23, 1996

Antiarthritic MMP inhibitor described by Chugai

Aug. 16, 1996

Kureha discloses MMP-inhibitory esculetin derivatives

Aug. 16, 1996

Nisshin Flour Milling describes agents for septic shock

Aug. 16, 1996

P-selectin inhibitors reported by BMS

Aug. 16, 1996

MGI Pharma issued Israeli marketing approval for Salagen line extension

Aug. 9, 1996

Palauolol: A novel antiinflammatory phospholipase A2 inhibitor

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 15, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...